Internal Medicine, Pulmonary Disease · Cleveland, OH
NPI
1144489204
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2500 Metrohealth Dr
Cleveland, OH, 44109
Phone (216) 778-7800
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
770 services
Medicare patients, 2024
269
Average age 71
Drug cost, 2024
$2.4M
2,990 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mirna B Ayache was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 61 times for 46 patients. In total Mirna B Ayache billed 770 services in 27 codes, and Medicare paid $19K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 61 | 46 | $12.08 | $737 |
| 94729 Pulmonary Function Testing | Office | 61 | 60 | $5.87 | $358 |
| 94726 Pulmonary Function Testing | Office | 57 | 56 | $8.07 | $460 |
| 94060 Pulmonary Function Testing | Office | 54 | 53 | $6.68 | $360 |
| 99215 Office E&M - Established | Office | 41 | 33 | $102.54 | $4,204 |
| 94010 Pulmonary Function Testing | Office | 38 | 38 | $5.62 | $214 |
| 99213 Office E&M - Established | Office | 36 | 31 | $42.88 | $1,544 |
| 94729 Pulmonary Function Testing | Facility | 33 | 33 | $6.10 | $201 |
| 94060 Pulmonary Function Testing | Facility | 31 | 31 | $6.67 | $207 |
| 94618 Pulmonary Function Testing | Office | 27 | 27 | $16.01 | $432 |
| 99214 Office E&M - Established | Office | 26 | 24 | $66.21 | $1,721 |
| 94726 Pulmonary Function Testing | Facility | 17 | 17 | $8.42 | $143 |
| 94727 Pulmonary Function Testing | Facility | 15 | 15 | $7.77 | $116 |
| 94618 Pulmonary Function Testing | Facility | 14 | 14 | $13.07 | $183 |
By year: 2022 $21K for 491 services; 2023 $19K for 560 services; 2024 $19K for 770 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mirna B Ayache prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 445 prescriptions and refills. In total Mirna B Ayache wrote 2,990 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 445 | 535 | 132 | $14K |
| Advair Hfa Fluticasone Propion/Salmeterol | 219 | 386 | 61 | $134K |
| Prednisone Generic | 216 | 223 | 93 | $548 |
| Dupixent Pen Dupilumab | 199 | 209 | 29 | $766K |
| Montelukast Sodium Generic | 185 | 393 | 51 | $1,647 |
| Spiriva Respimat Tiotropium Bromide | 124 | 171 | 34 | $86K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 119 | 152 | 23 | $97K |
| Symbicort Budesonide/Formoterol Fumarate | 118 | 203 | 45 | $47K |
| Fluticasone Propionate Generic | 101 | 195 | 43 | $1,318 |
| Spiriva Handihaler Tiotropium Bromide | 96 | 200 | 25 | $98K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 94 | 167 | 34 | $25K |
| Azithromycin Generic | 79 | 82 | 38 | $438 |
| Dulera Mometasone/Formoterol | 79 | 177 | 27 | $59K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 69 | 123 | 24 | $10K |
| Nucala Mepolizumab | 65 | 68 | 11 | $235K |
Brand drugs: 1,835 claims; generic drugs: 1,155 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mirna B Ayache were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.